Mar 15, 2023
Seeing Clearly
By Claire Zulkey How a routine vision check can save your life Jackie Memije assumed she was just stressed out, so she ignored her symptoms. The whooshing in the ears,…
Resources
Mar 15, 2023
How Melatonin Might Impact Your Eye Health
BY BETH BRADFORD Melatonin works in your brain to regulate your sleep cycle because it kicks in when there’s less light. Although your body produces it naturally, many of us take…
Mar 15, 2023
LumiThera Announces Sustained Vision Improvement for 24 months in Dry Age-Related Macular Degeneration Subjects from US LIGHTSITE III Clinical Trial Data
Press Release March 15, 2023, 07:17 AM Eastern Daylight Time SEATTLE–(BUSINESS WIRE)–LumiThera Inc., a medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the 24-…
Mar 14, 2023
Ocugen submits NDA with FDA to initiate phase 1 clinical trial evaluating OCU200 for treatment of DME
by: David Hutton The regulatory milestone fulfills the company’s goal to file the IND for OCU200 within the first quarter of 2023. Ocugen Inc. today announced that it has submitted…
Mar 7, 2023
MacuHealth & Macular Degeneration Association announce partnership
Press Release The Macular Degeneration Association and MacuHealth Announce Partnership BIRMINGHAM, Mich., March 07, 2023 – The Macular Degeneration Association, an organization dedicated to educating age-related macular degeneration (AMD)…
Mar 7, 2023
Eyedaptic unveils the EYE5 glasses with EyeSwitch™
The latest model in the Eyedaptic product showcase boasts comfort without sacrificing usability and adds brand-new artificial intelligence features. Laguna Hills, CA — October 24, 2022 —Eyedaptic, Inc., is excited to…
Feb 28, 2023
February as Low Vision and Age-Related Macular Degeneration (AMD) Awareness Month.
These conditions impact millions (AMD alone affects 196M) of individuals worldwide. This month highlights the importance of those with low vision seeking the appropriate care and management. Low Vision FAQ My…
Feb 28, 2023
AFLIBERCEPT 8 MG BLA FOR TREATMENT OF WET AGE-RELATED MACULAR DEGENERATION AND DIABETIC MACULAR EDEMA ACCEPTED FOR FDA PRIORITY REVIEW
Breaking News BLA supported by two pivotal trials demonstrating non-inferior vision gains to EYLEA® (aflibercept) Injection, with vast majority of patients maintaining extended dosing regimens through 48 weeks If approved, aflibercept…
Feb 22, 2023
Researchers identify a new genetic risk factor for age-related macular degeneration
Reviewed by Emily Henderson, B.SC. Researchers at Tel Aviv University identified a new genetic risk factor for the complex eye disease AMD (Age-related Macular Degeneration), a leading cause for loss…
Feb 19, 2023
FDA Approves Apellis’ SYFOVRE™, for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)
Newly approved treatment for Geographic Atrophy by FDA Geographic atrophy (GA) is the advanced form of dry age-related macular degeneration (AMD) which causes blindness in one million people in the…
Feb 13, 2023
February is AMD Awareness & Low Vision Month
Here are some helpful tips to help. 1. Speak to your eye care professional to see if there are any new treatments available. 2. If you have lost…
Feb 13, 2023
AMD-See the Day
New services available at CVS in Tampa, FL Don’t let age dim your vision. As we age, our eyes change, but not all changes are “natural” or inevitable-Related Macular Degeneration,…
Feb 9, 2023
FDA grants fast track designation for retinitis pigmentosa treatment
EA-2353 for the treatment of retinitis pigmentosa received fast-track designation from the FDA, according to a press release from Endogena Therapeutics. The gene-independent treatment approach activates endogenous retinal stem and progenitor…
Feb 7, 2023
February is Macular Degeneration & Low Vision Awareness month
Low vision looks different for everyone — literally. These are four examples of what blindness can look like. Blindness is a spectrum, it is rarely absolute, and understanding the low…
Jan 25, 2023
More Than 1 in 4 Americans Over 70 Has Impaired Vision
by: Dennis Thompson Key Takeaways More than a quarter of U.S. seniors is living with an untreated vision problem — nearsightedness, farsightedness, or impaired contrast sensitivity Trouble reading? This can…
Jan 17, 2023
Glaucoma Awareness Month
Glaucoma is a leading cause of vision loss and blindness in the United States. Glaucoma has no early symptoms — that’s why half of the people with glaucoma don’t know…
Jan 17, 2023
Clinical Trials & Early Access Program- Apellis
Clinical trials are a critical component of our efforts to deliver innovative therapies to people living with serious diseases, and they help to determine whether a new therapy is safe…
Jan 17, 2023
Tampa Vision Seminar
Join the Macular Degeneration Association and the Foundation Fighting Blindness, Tampa Chapter at TPepin’s Hospitality Centre. Secure your spot today! Tampa Vision Seminar Saturday, February 4, 2023 9:00 a.m. –…
Jan 16, 2023
Health Benefits of Dates: A Sweet Superfood for a Healthy Life
By Happy Sharer Introduction Dates are a popular sweet snack that has been enjoyed around the world for thousands of years. They are a type of dried fruit that is…
Jan 10, 2023
False Positive Neovascular AMD Results May Foretell Future Conversion
by: Lauren Dembeck, PhD ForeseeHome false positive alerts in fellow eyes to eyes with neovascular age-related macular degeneration predict future conversions. When a patient with previously diagnosed neovascular age-related macular…
Jan 2, 2023
The Macular Degeneration Association is proud to highlight Medical Board Member, JEREMIAH BROWN, JR., MS, MD
Dr. Jeremiah Brown, Jr. is a board-certified ophthalmologist with more than 10 years of practice experience as a Vitreoretinal Surgeon. He founded the Brown Retina Institute in 2010 to establish…
Jan 2, 2023
Late-Stage AMD Patients Needed: Study Underway to Evaluate a New-Generation Implantable Miniature Telescope
In 2010, the U.S. Food and Drug Administration (FDA) approved a novel device from Samsara Vision called the Implantable Miniature Telescope (IMT). The purpose of this device is to magnify…
Jan 1, 2023
Happy New Year 2023
The Macular Degeneration Association wanted to wish everyone a very Happy 2023.
Dec 27, 2022
More Than an Eye Exam: How Nutrition and Lifestyle Can Improve Eye Health
We have all heard the saying, “You are what you eat,” and nutrition gives us the power to choose our health outcome. by: Mila Ioussifova, OD, FAAO Nutrition plays a…
Dec 23, 2022
Retina Specialist and Optometrist Comanagement of AMD Patients
Eye care professionals can partner for optimal patient care. By Jeffry Gerson, OD; Rishi P. Singh, MD Although age-related macular degeneration (AMD) is a leading cause of vision loss for Americans 50…
Dec 19, 2022
My Accessible Kitchen Tour
In this video, I take a tour through my kitchen and show all the gadgets and tricks I use.
Dec 14, 2022
AmazonSmile
You can help support the Macular Degeneration Association at no additional cost. Simply add us to your charity choice on AmazonSmile. Thank you.
Dec 14, 2022
New potential mechanism for vision loss discovered
New research is being conducted but is not ready for release yet. by: David Hutton Researchers from the Deutsches Zentrum für Neurodegenerative Erkrankungen and the Center for Regenerative Therapies Dresden…
Dec 5, 2022
Putting stem cell-based therapies in context
Karen M. Wai, M.D., Theodore Leng, M.D., MS, and Jeffrey Goldberg, M.D., Ph.D., Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California. In recent years, the…
Nov 30, 2022
Matters of Vision! 2022 Last 2 meetings
EXCITING NEWS about dry macular degeneration is being presented at the Matters of Vision! 2022 last 2 meetings. 12.03.22 Atlanta, GA- Renaissance Concourse Airport Hotel- One Hartsfield Centre Parkway, Atlanta,…